Stay updated on Pembrolizumab + Palliative Radiotherapy in BC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Palliative Radiotherapy in BC Clinical Trial page.

Latest updates to the Pembrolizumab + Palliative Radiotherapy in BC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedNo additions or deletions detected between the screenshots; the study page content appears unchanged (title, eligibility criteria, and outcome measures remain the same). There were no changes to core content, names, pricing, stock, or time slot availability.SummaryDifference0.5%

- Check18 days agoNo Change Detected
- Check40 days agoChange DetectedUpdate headers: page now includes a government funding-lapse notice with operating-status guidance and links, and the version is upgraded to v3.2.0, replacing v3.1.0.SummaryDifference3%

- Check47 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.2%

- Check68 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%

- Check76 days agoChange DetectedThe web page has added a facility name and location related to skin and connective tissue diseases, while removing several related medical topics and previous location details.SummaryDifference2%

Stay in the know with updates to Pembrolizumab + Palliative Radiotherapy in BC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Palliative Radiotherapy in BC Clinical Trial page.